Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Author: Auditor

SOP for Safety Data Management

Posted on By

Protocol for Managing Safety Information in BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for the collection, evaluation, documentation, and reporting of safety data related to Bioavailability (BA) and Bioequivalence (BE) studies in the pharmaceutical industry. Scope This SOP applies to all study personnel involved in safety data…

Read More “SOP for Safety Data Management” »

Bioequivalence Bioavailability Study

SOP for Drug Return and Destruction

Posted on By

Protocol for Handling Returned and Expired Drugs in BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to define the procedures for the proper handling, documentation, and disposal of returned, expired, or unused investigational drugs used in Bioavailability (BA) and Bioequivalence (BE) studies in the pharmaceutical industry. Scope This SOP applies to…

Read More “SOP for Drug Return and Destruction” »

Bioequivalence Bioavailability Study

SOP for Handling Study Dropouts

Posted on By

Protocol for Managing Participant Withdrawals in BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for handling participant dropouts and withdrawals from Bioavailability (BA) and Bioequivalence (BE) studies conducted in the pharmaceutical industry. Scope This SOP applies to all study personnel involved in participant recruitment, enrollment, and study conduct,…

Read More “SOP for Handling Study Dropouts” »

Bioequivalence Bioavailability Study

SOP for Corrective and Preventative Actions (CAPA)

Posted on By

Protocol for Implementing CAPA in BA/BE Study Facilities Purpose The purpose of this Standard Operating Procedure (SOP) is to define the process for identifying, implementing, and verifying corrective and preventative actions (CAPA) to address non-conformities, deficiencies, and potential risks identified during Bioavailability (BA) and Bioequivalence (BE) studies in the pharmaceutical industry. Scope This SOP applies…

Read More “SOP for Corrective and Preventative Actions (CAPA)” »

Bioequivalence Bioavailability Study

SOP for Responding to Audit Findings

Posted on By

Protocol for Addressing Audit Observations in BA/BE Study Facilities Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for responding to audit findings and implementing corrective actions to address deficiencies identified during audits of Bioavailability (BA) and Bioequivalence (BE) study facilities in the pharmaceutical industry. Scope This SOP applies to all…

Read More “SOP for Responding to Audit Findings” »

Bioequivalence Bioavailability Study

SOP for Auditing Clinical and Bioanalytical Facilities

Posted on By

Protocol for Conducting Audits in BA/BE Study Facilities Purpose The purpose of this Standard Operating Procedure (SOP) is to outline the procedures for conducting audits of clinical and bioanalytical facilities involved in Bioavailability (BA) and Bioequivalence (BE) studies in the pharmaceutical industry. Scope This SOP applies to all personnel involved in auditing activities, including Auditors,…

Read More “SOP for Auditing Clinical and Bioanalytical Facilities” »

Bioequivalence Bioavailability Study

SOP for Conflict of Interest Disclosure

Posted on By

Protocol for Managing Conflict of Interest in BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for the identification, disclosure, and management of conflicts of interest among personnel involved in Bioavailability (BA) and Bioequivalence (BE) studies in the pharmaceutical industry. Scope This SOP applies to all study personnel, including…

Read More “SOP for Conflict of Interest Disclosure” »

Bioequivalence Bioavailability Study

SOP for Training of Study Personnel

Posted on By

Protocol for Study Personnel Training in BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for the training of personnel involved in the conduct and oversight of Bioavailability (BA) and Bioequivalence (BE) studies in the pharmaceutical industry. Scope This SOP applies to all study personnel, including Investigators, Study Coordinators,…

Read More “SOP for Training of Study Personnel” »

Bioequivalence Bioavailability Study

SOP for Regulatory Submission Preparation

Posted on By

Protocol for Compiling Regulatory Submissions for BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for the preparation, compilation, and submission of regulatory documents for Bioavailability (BA) and Bioequivalence (BE) studies conducted in the pharmaceutical industry. Scope This SOP applies to all personnel involved in the regulatory submission process,…

Read More “SOP for Regulatory Submission Preparation” »

Bioequivalence Bioavailability Study

SOP for Final Report Preparation

Posted on By

Protocol for Generating Final Study Reports in BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to outline the procedures and responsibilities for preparing comprehensive final reports for Bioavailability (BA) and Bioequivalence (BE) studies in the pharmaceutical industry. Scope This SOP applies to all personnel involved in the generation, review, and approval…

Read More “SOP for Final Report Preparation” »

Bioequivalence Bioavailability Study

Posts pagination

Previous 1 … 698 699 700 … 754 Next

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Free GMP Video Content

Before You Leave...

Don’t leave empty-handed. Watch practical GMP scenarios, inspection lessons, deviations, CAPA thinking, and real compliance insights on our YouTube channel. One click now can save you hours later.

  • Practical GMP scenarios
  • Inspection and compliance lessons
  • Short, useful, no-fluff videos
Visit GMP Scenarios on YouTube
Useful content only. No nonsense.